Clinical-Trial Opportunity Intelligence

Find the trials worth chasing — before your competitors do.

StudyIntel turns public trial data into a prioritized, interpreted brief for your BD team: which sponsors and studies to pursue, and why.

Not another database to mine. Not another alert feed to drown in. The opportunities, already read for what matters.

Subscribe now → See a live brief (free) →

BD Opportunity BriefCardiovascular

Factor XIa inhibitor — AF stroke preventionSignal · investigate

Bayer

NCT0XXXXXX1 · Phase 3 · Recruiting · 31 countries

Large global Phase 3 recently updated — worth a conversation about site and regional capacity.

siRNA Lp(a) lowering — CV outcomesSignal · investigate

Novartis

NCT0XXXXXX3 · Phase 3 · Recruiting · 20 countries

Active outcomes program in a fast-growing class; a lead to qualify, not a confirmed opening.

Built for BD teams at CROs SMOs Site networks

The difference

Most tools give you data. StudyIntel gives you the read.

The intelligence already exists in public registries. The hard part isn't finding it — it's deciding what's worth your team's time. That's the part StudyIntel does.

Data platforms

A searchable database

Powerful and broad — and you do the digging, across hundreds of fields, at enterprise prices. The interpretation is still on you.

Signal tools

A firehose of alerts

A stream of everything that moved. Useful, but you still have to separate the opportunity from the noise, every day.

StudyIntel

A prioritized brief

The trials worth chasing in your therapeutic areas — sponsor, phase, geography, and the reason it's worth a call. Interpreted, not dumped.

What you get

Briefs, reports, and alerts — tuned to your pipeline.

Three ways to stay ahead of where the work is going, all built on the same interpreted-intelligence engine.

Opportunity Briefs

A curated, prioritized read of the trials worth a BD conversation in your areas — each with the sponsor, the status, and the hook to investigate.

Landscape Reports

Scheduled reports on how your therapeutic areas are moving — what's newly posted, what's advancing, and what's winding down — so planning isn't guesswork.

Triggered Alerts

A note when something worth a call appears — a new Phase 3, a sponsor expanding into a region you cover — without the daily flood.

How it works

Public data in. A prioritized read out.

No black box. The source is public, the reasoning is shown, and the limits are stated plainly.

Public trial data in

We pull live from ClinicalTrials.gov and other public registries across your therapeutic areas and geographies.

Interpreted & prioritized

The engine reads the data and surfaces the opportunities that matter to your team — with the reasoning attached, not just a list.

Delivered to your team

Briefs, reports, and alerts reach your BD seats on a cadence you set — ready to act on, not to process.

Signals to investigate, not confirmed openings. Every opportunity is grounded in public registry data and framed as a lead to qualify. StudyIntel never fabricates a sponsor's intent, budget, or who to call — it points your team where to look, faster.

See StudyIntel on your therapeutic areas.

Subscribe and get a full opportunity brief built for the areas your team covers — or try a free preview above first.

Full prioritized briefs, not just the free preview
Daily Radar — StudyIntel remembers every study and flags what changes
Team pricing — subscription per organization, seats for your BD users

Subscribe now →

Prefer to send a note first? Use the form and we'll reach out.